Xiaofei Ye

Karolinska Institutet - Department of Biosciences and Nutrition

Hälsovägen 7-9/NEO

SE-141 83 Huddinge , Stockholm

Sweden

SCHOLARLY PAPERS

1

DOWNLOADS

33

TOTAL CITATIONS

1

Scholarly Papers (1)

1.

RNA-Editing-Initiated MAVS Signaling is a Key Epitranscriptomic Alteration in Human B Cell Lymphoma

Number of pages: 62 Posted: 20 Sep 2021
German Cancer Research Center (DKFZ) - Division of Immune Diversity, Karolinska Institutet - Department of Biosciences and Nutrition, Tianjin Medical University - Department of Lymphoma, Karolinska Institutet - Department of Biosciences and Nutrition, Tianjin Medical University - Department of LymphomaTianjin Medical University - Key Laboratory of Cancer Prevention and Therapy, German Cancer Research Center (DKFZ) - Division of Immune Diversity, German Cancer Research Center (DKFZ) - Division of Immune Diversity, Karolinska Institutet - Department of Biosciences and Nutrition, German Cancer Research Center (DKFZ) - Division of Immune Diversity, German Cancer Research Center (DKFZ) - Research Group "Dynamics of Early Viral Infection and the Innate Antiviral Response", University of Tübingen - Interfaculty Institute of Biochemistry, University of Tübingen - Interfaculty Institute of Biochemistry, University of Tübingen - Interfaculty Institute of Biochemistry, Uppsala University - Department of Immunology, Genetics and Pathology, Clinical and Experimental Oncology, Uppsala University - Department of Immunology, Genetics and Pathology, Clinical and Experimental Oncology, Karolinska Institutet - Hematology Unit, Karolinska InstitutetKarolinska Institutet - Hematology Unit, Tianjin Medical University - Key Laboratory of Cancer Prevention and Therapy, German Cancer Research Center (DKFZ) - Research Group "Dynamics of Early Viral Infection and the Innate Antiviral Response", German Cancer Research Center (DKFZ) - Division of Immune Diversity (D150) and Karolinska Institutet - Department of Biosciences and Nutrition
Downloads 33 (1,022,653)
Citation 1

Abstract:

Loading...

Epitranscriptomics, RNA editing, cancer, B cell lymphoma, disease progression, RLR pathway, targeted base editing therapeutics